|
MRSA strain
|
Number of patients (n = 1598)
|
Number of staff members (n = 109)
|
Total no. of isolates
|
|---|
| |
Sequence type (ST) and SCCmec type
|
Clinical specimen
|
aScreening specimen; exposure to MRSA
|
bScreening specimen; hospital contact abroad
|
Other reason for taking the sample
|
Clinical specimens
|
cScreening specimen; epidemic situation
|
dScreening specimen; hospital contact abroad
|
Other reason for taking the sample
| |
|---|
|
FIN-16
|
ST125:IA
|
197
|
131
|
5
|
18
|
2
|
3
|
1
|
2
|
359
|
|
FIN-7
|
ST8:IV
|
70
|
159
|
1
|
6
|
-
|
28
|
-
|
-
|
264
|
|
FIN-4
|
ST375:IV
|
163
|
56
|
5
|
12
|
4
|
8
|
-
|
-
|
248
|
|
FIN-10
|
ST45:IV, V
|
87
|
129
|
2
|
6
|
2
|
12
|
-
|
-
|
238
|
|
FIN-21
|
ST228:I
|
58
|
82
|
1
|
3
|
-
|
1
|
-
|
-
|
145
|
|
FIN-3
|
ST5:II
|
22
|
30
|
8
|
7
|
-
|
4
|
-
|
-
|
71
|
|
FIN-15
|
ST8:IV
|
34
|
19
|
-
|
5
|
-
|
9
|
-
|
1
|
68
|
|
FIN-12
|
ST22:IV
|
19
|
12
|
8
|
4
|
-
|
1
|
14
|
-
|
58
|
|
FIN-6
|
ST36:II
|
5
|
1
|
5
|
-
|
-
|
1
|
1
|
-
|
13
|
|
eFIN-2
|
ST241:IIIB
|
7
|
-
|
2
|
-
|
-
|
-
|
-
|
-
|
9
|
|
Other strains
| |
79
|
49
|
8
|
2
|
3
|
5
|
2
|
2
|
150
|
|
Sporadic
| |
52
|
22
|
19
|
2
|
1
|
1
|
1
|
-
|
98
|
|
Total
| |
793
|
690
|
64
|
65
|
12
|
73
|
19
|
5
|
f1721
|
-
aScreening specimens of MRSA increased from 36% (96/265) in 2001 to 45% (364/816) in 2003.
-
bHospitalized or undergone a surgical procedure outside the Nordic countries within 6 months
-
cScreening specimens of MRSA increased from 46% (12/26) in 2001 to 82% (36/44) in 2002, but decreased to 64% (25/39) in 2003.
-
dWorked outside the Nordic countries within 6 months
-
eThis represents only FIN-2e subtype.
-
fThe total number of strains (1721) exceeds the number of MRSA-positive persons (1707) by 14, because in some cases more than one reason for sampling was chosen in the questionnaire.
